We Help Companies Find New Sales Opportunities
Renovo is to acquire Ultimate Finance Group, the Bristol-based financial services firm, for £19m.
Renovo is planning to shed up to one third of the 180 jobs at its Manchester-based biotechnology business, in order to focus on the development of anti-scarring drugs.
Renovo is to relocate its Manchester-based medical research business to a new 25,000 sq ft site at the University of Manchester Incubator Company's core technology facility by the end of the year.
Renovo is reviving plans to raise up to £40m in a flotation to fund the development of its Manchester-based biotechnology business.
Renovo is planning to raise £50m in a flotation to fund the development of an anti-scarring drug.
Renovo has secured a further £21m of venture capital to fund the development of embryonic cell technology to help with the healing of wounds.